z-logo
open-access-imgOpen Access
Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations
Author(s) -
Randy F. Sweis,
Brian L. Heiss,
Jeremy P. Segal,
Lauren L. Ritterhouse,
Sabah Kadri,
Jane E. Churpek,
Kenisha Allen,
Dawn Conway,
Carolyn Marinier,
Norm D. Smith,
Sean P. Pitroda,
Walter M. Stadler
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00264
Subject(s) - olaparib , urothelial cancer , dna damage , cancer research , bladder cancer , gene , medicine , mutation , oncology , dna , cancer , biology , genetics , poly adp ribose polymerase , polymerase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom